All Blogs

Jun 07, 2022

FDA Gives Green Signal to First Measles Vaccine in Almost 50 Years GSK announced that the company's vaccine for protection against mumps, measles, and rubella (MMR) had been approved by the U.S. FDA. According to data from six clinical studies, the company filed a Biologics License Application in August 2021. ...

Jul 03, 2026

Developmental and epileptic encephalopathies (DEEs) have evolved from symptom control toward precision neurology, with the market anchored by EPIDIOLEX (cannabidiol, Jazz Pharmaceuticals), initially approved in the US in 2018 for Dravet syndrome and Lennox–Gastaut syndrome (LGS) and later expanded to tuberous scler...

Jun 03, 2022

Diabetic Retinopathy (DR), a microvascular disease, is an eye condition in diabetic patients, affecting blood vessels in the retina and causing significant visual loss in working populations. The retina needs a constant supply of blood, which it receives through a network of tiny blood vessels. Constant high blood ...

Jun 02, 2022

GenScript USA Announced the Distribution Agreement with EUROIMMUN US for cPass SARS-CoV-2 Neutralizing Antibody Detection Kit On May 26, 2022, GenScript USA Inc., a subsidiary of GenScript Biotech Corporation and a world-leading biotechnology company, agreed with EUROIMMUN US Inc., a PerkinElmer Company, for the...

Jun 01, 2022

An ongoing virus has made us all intrigued and worried, and it is none other than the Monkeypox virus. It was considered to be a rare disease caused by an infection due to the Monkeypox virus. Now on a consistent rise, the zoonosis human Monkeypox (MPX) was originated way back in the year 1958 when two outbreaks of...

May 31, 2022

Bristol-Myers Squibb’s Opdivo Gets FDA Approval for Esophageal Cancer The FDA has approved two combination drug regimens based on Bristol-Myers Squibb’s PD-1 inhibitor Opdivo for previously untreated advanced Esophageal Cancer, encroaching on the territory belonging to Merck & Co’s rival Keytruda. The latest...

May 30, 2022

Obstructive Sleep Apnea (OSA) is a common, chronic, sleep-related breathing disorder characterized by periodic narrowing and obstruction of the pharyngeal airway during sleep, leading to either complete or partial obstruction of the airway, resulting in apneas, hypopneas, or both. Obstructive Sleep Apnea causes day...

May 27, 2022

The Dry AMD market is a billion-dollar business opportunity today as around 80–90% of individuals are affected by it. As per DelveInsight analysis, there were approximately 34.9 million cases of Dry AMD in 2021. Moreover, in 10–15% of patients with Dry AMD, the deterioration is more rapid and extensive, and they su...

May 26, 2022

Accleus Receives Regulatory Approval from US FDA for Toro-L Interbody Fusion System On May 19, 2022, the US Food and Drug Administration (FDA) granted the regulatory approval to Toro-L interbody fusion system developed by Accleus. The device is a biplanar expandable lateral implant designed for a minimal inserti...

Jul 14, 2025

Cloud computing in healthcare has become a cornerstone of modern medical IT services, revolutionizing how medical data is stored, accessed, shared, and analyzed. The COVID-19 pandemic significantly accelerated the adoption of cloud computing in the healthcare industry, pushing hospitals, clinics, and research insti...